Skip to content

Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01589224
Enrollment
150
Registered
2012-05-01
Start date
2012-05-31
Completion date
Unknown
Last updated
2015-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Metabolic Syndrome

Brief summary

Coronary MDCT (multi-detector computed tomography) has been useful screening imaging modality for the coronary artery disease. Recently, novel adipokines and hepatokines as well as various inflammatory markers have been known as direct regulators of atherosclerosis. Therefore, the investigators examine the correlation of various metabolic risk factors including adipokines and hepatokines with coronary atherosclerosis measured by coronary MDCT in apparently healthy people.

Interventions

None listed

Sponsors

Korea University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Apparently healthy people who underwent medical routine check up in Korea Health Promotion Center. * age \> 20 years

Exclusion criteria

* History of cardiovascular disease (myocardial infarction, unstable angina, stroke, or cardiovascular revascularization) * Diabetes * Stage 2 hypertension * Severe renal or hepatic disease

Design outcomes

Primary

MeasureTime frameDescription
relation of adipokines and hepatokines with coronary atherosclerosis measured by MDCT3monthto examine the correlation of serum concentration of various adipokine such as adiponectin, resistin, A-FABP with coronary atheroslcerosis measured by MDCT as AGATSTON score, modified Gensini score

Secondary

MeasureTime frameDescription
relation of adipokines and hepatokines with coronary atherosclerosis measured by MDCT3monthsto examine the correlation of serum concentration of various hepatokines such as FGF-21, fetuin- A and selenoprotein P with coronary atheroslcerosis measured by MDCT as AGATSTON score, modified Gensini score
the correlation of various inflammatory markers with coronary atherosclerosis3months

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026